Gustavo A. Angarita, MD, MHS

Natarajan A, Angarita G, Gaiser E, Malison R, Ganesan D, Marlin BM. Domain adaptation methods for improving lab-to-field generalization of cocaine detection using wearable ECG. 2016, 2016: 875-885. PMID: 28090605, PMCID: PMC5235327, DOI: 10.1145/2971648.2971666.

Natarajan A, Gaiser E, Angarita G, Malison R, Ganesan D, Marlin B. Conditional random fields for morphological analysis of wireless ECG signals. 2014, 2014: 370-379. PMID: 26726321, PMCID: PMC4697765, DOI: 10.1145/2649387.2649414.

Angarita GA, Canavan SV, Forselius E, Bessette A, Pittman B, Morgan PT. Abstinence-related changes in sleep during treatment for cocaine dependence. Drug And Alcohol Dependence 2013, 134: 343-347. PMID: 24315572, PMCID: PMC4396819, DOI: 10.1016/j.drugalcdep.2013.11.007.

Angarita GA, Pittman B, Gueorguieva R, Kalayasiri R, Lynch WJ, Sughondhabirom A, Morgan PT, Malison RT. Regulation of cocaine self-administration in humans: Lack of evidence for loading and maintenance phases. Pharmacology Biochemistry And Behavior 2009, 95: 51-55. PMID: 20005893, PMCID: PMC2824073, DOI: 10.1016/j.pbb.2009.12.005.

Loebl T, Angarita GA, Pachas GN, Huang KL, Lee SH, Nino J, Logvinenko T, Culhane MA, Evins AE. A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men. The Journal Of Clinical Psychiatry 2008, 69: 480-6. PMID: 18294021, DOI: 10.4088/jcp.v69n0321.

Angarita GA, Reif S, Pirard S, Lee S, Sharon E, Gastfriend DR. No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria. Journal Of Addiction Medicine 2007, 1: 79-87. PMID: 21768939, DOI: 10.1097/ADM.0b013e3180634c1d.

Pirard S, Sharon E, Kang SK, Angarita GA, Gastfriend DR. Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes. Drug And Alcohol Dependence 2005, 78: 57-64. PMID: 15769558, DOI: 10.1016/j.drugalcdep.2004.09.005.